drugset / Trial / NCT05245721

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

NCT05245721

Phase 1 Unknown 80 enrolled Assiut University
RandomizedParallel-groupSingle-blindPrevention

Summary

Effect of caudal nalbuphine on postoperative emergence agitation in pediatrics undergoing infra-umbilical surgeries and pain assessment

Timeline

Start
2022-03
Primary completion
2023-01
Completion
2023-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified Other
Comparator Nalbuphine Small molecule Other

Indications

No indication recorded.